Biospecimen Services
End-to-end biospecimen collection, processing, storage, and shipment for pre-clinical research
Company profile
Company profile
Circuit Clinical is an Integrated Research Organization (IRO) on a mission to transform how people access and experience clinical trials. Founded in 2016 and headquartered in Buffalo, New York, the company brings clinical research directly to community healthcare settings rather than requiring patients to travel to traditional academic research centers. Circuit Clinical has built one of the largest IROs in the United States, providing direct EMR access to over 2.5 million participants within their partner health systems. The company operates through multiple Community Research Networks, including a Growing Site Partnership Network embedded in communities and a Remote Site Network of Principal Investigators across the US. Their approach enables physicians to conduct clinical research in-office, online, or through hybrid models, with dedicated medical, legal, and regulatory staff handling backend operations. Circuit Clinical serves three primary constituencies: patients seeking clinical trials as a care option, physicians wanting to conduct research, and industry sponsors/CROs needing recruitment and enrollment support. Circuit Clinical's solutions include traditional on-site Phase I-IV clinical trial management, biospecimen collection and processing services, and MD PreScreen—a proprietary screening service led by experienced research nurses. The company has completed over 300 clinical projects and works with 150+ Principal Investigators across 20+ physician groups in eight geographic regions. Their strategic partnerships include Medidata (creating turnkey DCT solutions), Labcorp (expanding access through FQHCs), and NextGen Healthcare (leveraging comprehensive data for diverse trial recruitment). Circuit Clinical is committed to democratizing clinical trials and improving representation in medical research.
Company description Circuit Clinical official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid · On Premise · Service deployment with recorded integration context.
Recorded integration context: EMR systems, Medidata Rave, Medidata TrialJourney, myMedidata, NextGen Healthcare.
Company milestones
Partnership with Western New York Medical (July 2025); Partnership with Mercer Allergy & Pulmonary Associates (August 2024); SSM Health partnership for oncology trials (January 2024); Graves Gilbert partnership in Kentucky (September 2023); Terminated merger agreement with Lightship Inc. (July 2025); Moderna mResvia RSV vaccine approval involvement (June 2024)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
End-to-end biospecimen collection, processing, storage, and shipment for pre-clinical research
Traditional on-site Phase I-IV clinical trial management for diverse populations
Expert screening service optimizing clinical trial participant lead generation
Always-ready network of Principal Investigators conducting decentralized clinical trials across the US
Community-embedded clinical trial sites bringing research to underrepresented populations
Patient-facing platform for clinical trial awareness and engagement
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
American journal of respiratory and critical care medicine · May 1, 2025
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.JAMA · Feb 14, 2023
Clinical validation
NCT06338995 · Mentioned · RECRUITING
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNCT06119581 · Mentioned · RECRUITING
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)NCT06717347 · Mentioned · RECRUITING
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 DiabetesNCT06144554 · Mentioned · RECRUITING
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)NCT06430801 · Mentioned · RECRUITING
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)NCT07060807 · Mentioned · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Direct EMR access within partner health systems
Completed clinical trials
In network
In partnership network
Coverage across US
Partnership to expand access to leading-edge oncology trials through clinical research
Expanded oncology trial access in community healthcare settings
Partnership with Circuit Clinical and Labcorp to bring clinical trials to patients across South Central Kentucky
Brought clinical trial access to previously underserved South Central Kentucky region
Created industry's first turnkey DCT solution by integrating Rave, TrialJourney, and myMedidata to expand access and elevate patient experience
Created unified decentralized clinical trial experience through strategic partnership
Partnership to create fully functional clinical trial sites in communities through Labcorp's network of providers, physicians, and FQHCs
Expanded access to clinical trials in underrepresented communities through FQHC network
Combined NextGen's comprehensive data and national reach with Circuit's patient-centric recruitment services
Groundbreaking opportunities for accelerating therapeutic development and improving diversity in clinical trials
05 · Leadership
Leadership profiles and professional links from the current Company record.
Irfan Khan
CEO & Founder
Kerry Hicks
Executive Chairman
Susanne Oltz
Chief Financial Officer
Margaret Scott
Senior Vice President, Clinical Operations
Laura Warwick
Senior Vice President, Commercial
Kathy Bean
Vice President, Technology & Clinical Informatics
06 · Company updates
Recent articles published on Circuit Clinical's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.